elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27310843-3D0FC6BB-3DF9-4ED1-81BD-505F5CAD65C0
Q27310843-3D0FC6BB-3DF9-4ED1-81BD-505F5CAD65C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27310843-3D0FC6BB-3DF9-4ED1-81BD-505F5CAD65C0
Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513.
P2860
Q27310843-3D0FC6BB-3DF9-4ED1-81BD-505F5CAD65C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27310843-3D0FC6BB-3DF9-4ED1-81BD-505F5CAD65C0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be3272822b0bd39c30fc2034869ef0480287d024
P2860
Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology